Baker Hughes BKR
$47.87 +$1.67 (+3.61%)
Pre-market · Nov 9, 4:50 am ET · After hours $47.87 0.00%
Open$46.48
Prev close$46.20
Day range$46.03 – $48.36
Volume12.65M
Market cap$47.54B
P/E (TTM)16.5
Dividend yield1.92%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$8.03B+14.5% YoY
Operating profit$881.00M-7.1% YoY
Net profit$422.00M-31.6% YoY
Diluted EPS$0.41-32.8% YoY
Free cash flow$734.00M+15.8% YoY
Operating cash flow$1.01B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin23.5%
Operating margin12.3%
Net margin10.1%
Return on equity15.1%
Return on assets5.9%
Return on invested capital10.4%
Current ratio1.24
Liabilities / assets65.2%
Cash & investments$4.07B
Total debt$18.26B
Net cash (debt)-$14.20B
Free cash flow / sales11.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $8.03B | $6.74B | $6.59B | $27.73B | $7.39B |
| Total Operating Revenue | $8.03B | $6.74B | $6.59B | $27.73B | $7.39B |
| Cost of Revenue | $6.10B | $5.17B | $5.08B | $21.19B | $5.63B |
| Gross Profit | $1.93B | $1.58B | $1.50B | $6.54B | $1.75B |
| Operating Expense | $1.05B | $712.00M | $695.00M | $2.99B | $783.00M |
| Selling and Admin Expenses | $732.00M | $569.00M | $562.00M | $2.39B | $671.00M |
| Research & Development | $150.00M | $143.00M | $133.00M | $600.00M | $147.00M |
| Depreciation & Amortization & Depletion | $165.00M | – | – | – | – |
| -Depreciation & Amortization | $165.00M | – | – | – | – |
| Operating Profit | $881.00M | $865.00M | $809.00M | $3.56B | $970.00M |
| Net Non-Operating Interest Income (Expense) | -$177.00M | -$66.00M | -$86.00M | -$222.00M | -$61.00M |
| Non-Operating Interest Expense | $177.00M | $66.00M | $86.00M | $222.00M | $61.00M |
| Other Income (Expense) | -$185.00M | $93.00M | $551.00M | -$458.00M | -$381.00M |
| Special Income (Charges) | -$28.00M | -$65.00M | $656.00M | -$322.00M | -$322.00M |
| -Less:Restructuring and Mergern & Acquisition | $28.00M | $41.00M | $65.00M | $229.00M | $229.00M |
| Other Non-Operating Income (Expenses) | -$157.00M | $33.00M | -$55.00M | -$33.00M | $44.00M |
| Pretax Profit | $519.00M | $892.00M | $1.27B | $2.88B | $528.00M |
| Tax | $97.00M | $210.00M | $336.00M | $253.00M | -$359.00M |
| Net Profit | $422.00M | $682.00M | $938.00M | $2.62B | $887.00M |
| Profit from Continuing Operations | $422.00M | $682.00M | $938.00M | $2.62B | $887.00M |
| Minority Interests | $11.00M | $1.00M | $8.00M | $36.00M | $11.00M |
| Net Income to Parent Company | $411.00M | $681.00M | $930.00M | $2.59B | $876.00M |
| Net Income to Common Stockholders | $411.00M | $681.00M | $930.00M | $2.59B | $876.00M |
| Basic EPS | $0.41 | $0.69 | $0.94 | $2.62 | $0.89 |
| Diluted EPS | $0.41 | $0.68 | $0.93 | $2.60 | $0.88 |
| Dividend Per Share | $0.23 | $0.23 | $0.23 | $0.92 | $0.23 |
| Gain on Sale of Security | – | $125.00M | -$50.00M | -$103.00M | – |
| -Gain on Sale Of Business | – | -$24.00M | $721.00M | – | – |
| -Less:Impairment of Capital Assets | – | – | – | $53.00M | – |
| -Less:Other Special Charges | – | – | – | $40.00M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $59.06B | $52.62B | $50.90B | $40.88B | $40.88B |
| Total Current Assets | $21.64B | $30.58B | $28.59B | $18.83B | $18.83B |
| Cash and Cash Equivalents & Short-Term Investments | $4.07B | $15.73B | $14.76B | $3.72B | $3.72B |
| -Cash and Cash Equivalents | $4.07B | $15.73B | $14.76B | $3.72B | $3.72B |
| Receivables | $7.87B | $6.65B | $6.70B | $6.64B | $6.64B |
| -Accounts Receivable | $6.94B | $5.55B | $5.51B | $5.56B | $5.56B |
| -Other Receivables | $1.20B | $1.40B | $1.48B | $1.36B | $1.36B |
| -Receivables Adjustments Allowances | -$268.00M | -$295.00M | -$290.00M | -$277.00M | -$277.00M |
| Inventory | $5.98B | $4.96B | $4.87B | $4.95B | $4.95B |
| Other Current Assets | $3.73B | $3.24B | $2.26B | $3.52B | $3.52B |
| Total Non-Current Assets | $37.42B | $22.04B | $22.31B | $22.05B | $22.05B |
| Net PPE | $6.78B | $5.54B | $5.54B | $5.33B | $5.33B |
| -Gross PPE | $13.97B | $12.52B | $12.37B | $12.01B | $12.01B |
| -Accumulated Depreciation | -$7.20B | -$6.98B | -$6.83B | -$6.69B | -$6.69B |
| Goodwill and Other Intangible Assets | $23.67B | $9.56B | $10.11B | $10.17B | $10.17B |
| -Goodwill | $13.90B | $5.57B | $6.03B | $6.07B | $6.07B |
| -Other Intangible Assets | $9.77B | $4.00B | $4.07B | $4.10B | $4.10B |
| Non-Current Deferred Assets | $1.61B | $1.89B | $1.73B | $1.96B | $1.96B |
| Other Non-Current Assets | $5.37B | $3.09B | $3.18B | $2.99B | $2.99B |
| Total Liabilities | $38.50B | $32.54B | $31.41B | $21.87B | $21.87B |
| Total Current Liabilities | $17.48B | $14.60B | $13.41B | $13.88B | $13.88B |
| Payables | $5.20B | $4.51B | $4.26B | $4.58B | $4.58B |
| -Accounts Payable | $5.20B | $4.51B | $4.26B | $4.58B | $4.58B |
| Short-Term Debt and Capital Lease Obligation | $788.00M | $774.00M | $753.00M | $689.00M | $689.00M |
| -Current Debt | $788.00M | $774.00M | $753.00M | $689.00M | $689.00M |
| Current Deferred Liabilities | $8.04B | $6.60B | $6.00B | $5.90B | $5.90B |
| Other Current Liabilities | $3.45B | $2.72B | $2.40B | $2.71B | $2.71B |
| Total Non-Current Liabilities | $21.03B | $17.94B | $17.99B | $7.99B | $7.99B |
| Long Term Debt and Capital Lease Obligation | $17.48B | $15.48B | $15.41B | $5.40B | $5.40B |
| -Long Term Debt | $17.48B | $15.48B | $15.41B | $5.40B | $5.40B |
| Non-Current Deferred Liabilities | $701.00M | $100.00M | $94.00M | $84.00M | $84.00M |
| Employee Benefits | $978.00M | $959.00M | $1.04B | $1.07B | $1.07B |
| Other Non-Current Liabilities | $1.87B | $1.40B | $1.45B | $1.45B | $1.45B |
| Total Equity | $20.56B | $20.08B | $19.49B | $19.01B | $19.01B |
| Stockholders' Equity | $20.13B | $19.91B | $19.31B | $18.83B | $18.83B |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $24.17B | $24.33B | $24.48B | $24.74B | $24.74B |
| Retained Earnings | -$1.23B | -$1.64B | -$2.32B | -$3.25B | -$3.25B |
| Gains/Losses Not Affecting Retained Earnings | -$2.81B | -$2.78B | -$2.84B | -$2.65B | -$2.65B |
| Minority Interests | $428.00M | $176.00M | $176.00M | $176.00M | $176.00M |
| Non Current Accounts Receivables | – | $1.95B | $1.75B | $1.62B | $1.62B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.01B | $1.35B | $500.00M | $3.81B | $1.66B |
| Net cash flow from continuing operations | $1.01B | $1.35B | $500.00M | $3.81B | $1.66B |
| Net Income from Continuing Operations | $422.00M | $682.00M | $938.00M | $2.62B | $887.00M |
| Gain/Loss from Continuing Operations | $0.00 | $24.00M | -$721.00M | $103.00M | – |
| Depreciation & Depletion & Amortization | $505.00M | $333.00M | $354.00M | $1.19B | $327.00M |
| Deferred Tax | -$244.00M | -$166.00M | $224.00M | -$702.00M | -$658.00M |
| Change in Working Capital | $271.00M | $540.00M | -$390.00M | $394.00M | $982.00M |
| -Change in Receivables | -$691.00M | -$220.00M | -$155.00M | $681.00M | -$69.00M |
| -Change in Inventory | -$70.00M | -$131.00M | $35.00M | $79.00M | $42.00M |
| -Change in Payables and Accrued Expense | $63.00M | $266.00M | -$248.00M | $11.00M | $346.00M |
| -Change In Other Working Capital | $969.00M | $625.00M | -$22.00M | -$377.00M | $663.00M |
| Net cash flow from investing | -$14.28B | -$164.00M | $1.04B | -$2.04B | -$393.00M |
| Net Cash Flow from Continuing Investing Activities | -$14.28B | -$164.00M | $1.04B | -$2.04B | -$393.00M |
| Capital Expenditure | -$271.00M | -$300.00M | -$336.00M | -$1.27B | -$377.00M |
| Net Business Purchase and Sale | -$14.08B | $0.00 | $1.38B | -$830.00M | -$30.00M |
| Net Other Investing Changes | $76.00M | $136.00M | -$7.00M | $58.00M | $13.00M |
| Financing Cash Flow | $1.62B | -$236.00M | $9.52B | -$1.48B | -$258.00M |
| Net Cash Flow from Continuing Financing Activities | $1.62B | -$236.00M | $9.52B | -$1.48B | -$258.00M |
| Net Issuance Payments Of Debt | $2.00B | $0.00 | $9.89B | $0.00 | $0.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | -$384.00M | $0.00 |
| Cash Dividends Paid | -$228.00M | -$228.00M | -$228.00M | -$910.00M | -$227.00M |
| Net Other Financing Charges | -$154.00M | -$8.00M | -$134.00M | -$188.00M | -$31.00M |
| Ending Cash Balance | $4.07B | $15.73B | $14.76B | $3.72B | $3.72B |
| Net Change in Cash | -$11.65B | $945.00M | $11.06B | $284.00M | $1.01B |
| Beginning Cash Balance | $15.73B | $14.76B | $3.72B | $3.36B | $2.69B |
| Effect of Exchange Rate Changes | -$6.00M | $18.00M | -$12.00M | $67.00M | $11.00M |
| Free Cash Flow | $734.00M | $1.05B | $164.00M | $2.54B | $1.29B |
| Net Investment Purchase and Sale | – | – | – | $1.00M | $0.00 |
No comments yet — be the first to weigh in on BKR.
Sign in to join the discussion.